Application Nr Approved Date Route Status External Links
NDA018676 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hepatamine® Is Indicated For The Treatment Of Hepatic Encephalopathy In Patients With Cirrhosis Or Hepatitis. Hepatamine® Provides Nutritional Support For Patients With These Diseases Of The Liver Who Require Parenteral Nutrition And Are Intolerant Of General Purpose Amino Acid Injections, Which Are Contraindicated In Patients With Hepatic Coma.

All Formulated Excipients (0 Total)